Radionuclide Decorporation Agents for Radiation/Nuclear Emergencies: Project BioShield (R01)

The summary for the Radionuclide Decorporation Agents for Radiation/Nuclear Emergencies: Project BioShield (R01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Radionuclide Decorporation Agents for Radiation/Nuclear Emergencies: Project BioShield (R01): This is a funding opportunity announcement (FOA) to accelerate the development of safe and effective products to remove radionuclides from the body (decorporation) following nuclear contamination from any source. Specifically, candidate products will demonstrate an increase in efficiency and rate of radionuclide elimination from the body after contamination due to ingestion, inhalation or transdermal absorption.-In FY 2006, the NIAID intends to commit up to $4 million to support research projects focused on the development of novel radionuclide chelation and decorporation agents. -Support will be provided for up to $1 million in total costs per award for a project period not to exceed eighteen (18) months. -It is anticipated that 4-6 awards will be made in 2006. -This FOA will use the R01 funding mechanism. -Eligible organizations: For-profit organizations; Non-profit organizations; Public or private institutions, such as universities, colleges, hospitals, and laboratories; Units of State government; Units of local government; Eligible agencies of the Federal government; Domestic Institutions (Foreign institutions/organization may apply as a subcontractor to a qualifying U.S. domestic institution/organization).-Eligible principal investigators include experienced scientists with leadership and administrative skills commensurate with those required to lead an R01 or similar award mechanism. -Applicants may not submit more than one application in response to this FOA. -See Section IV.1 for application materials. -Send applications directly to NIAID not to CSR per instructions.-Special Review by NIAID per BioShield Act 2004-Telecommunications for the hearing impaired is available at: TTY 301-451-0088

Federal Grant Title:	Radionuclide Decorporation Agents for Radiation/Nuclear Emergencies: Project BioShield (R01)
Federal Agency Name:	National Institutes of Health
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-AI-06-030
Type of Funding:	Grant
CFDA Numbers:	93.855
CFDA Descriptions:	Allergy, Immunology and Transplantation Research
Current Application Deadline:	No deadline provided
Original Application Deadline:	May 16, 2006
Posted Date:	Mar 30, 2006
Creation Date:	Mar 30, 2006
Archive Date:	Jun 15, 2006
Total Program Funding:	$4,000,000
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: Special district governments City or township governments Public housing authorities/Indian housing authorities Private institutions of higher education Public and State controlled institutions of higher education County governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled "Additional Information on Eligibility" for clarification) Independent school districts Native American tribal governments (Federally recognized) For profit organizations other than small businesses State governments
Additional Information on Eligibility: Foreign institutions are not eligible to apply. Eligible agencies of the Federal Government are eligible to apply. Foreign institutions/organizations may apply as a subcontractor to qualifying U.S. domestic institutions/organizations
Link to Full Grant Announcement: Information not provided
Grant Announcement Contact: NIH OER Webmaster
[email protected]
[email protected] If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Similar Government Grants: • Discovery and Development of Novel Therapeutics for Select Fungal Pathogens (R21/R33 Clini...; • Strategies for Eliminating HIV Proteins (R21 Clinical Trial Not Allowed); • Strategies for Eliminating HIV Proteins (R01 Clinical Trial Not Allowed); • Promoting Innovative Research in Treponema pallidum Pathogenesis (R21 Clinical Trial Not A...; • Novel Approaches for Radiation Biodosimetry and Medical Countermeasure Development (R21 Cl...; • Center for HIV/AIDS Vaccine Immunology (CHAVI); • Genomics of Transplantation Cooperative Research Program; • Asthma and Allergic Diseases Cooperative Research Centers
More Grants from the National Institutes of Health: • Analytical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders...; • Scaling-up and Maintaining Evidence-based Interventions to Maximize Impact on Cancer (SUMM...; • Scaling-up and Maintaining Evidence-based Interventions to Maximize Impact on Cancer (SUMM...; • NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed...; • Research Experiences and/or Mentoring Networks through Research Education to Enhance Clini...